Certain Pre-Funded Warrants of Mirati Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 10-JAN-2022. These Pre-Funded Warrants will be under lockup for 61 days starting from 10-NOV-2021 to 10-JAN-2022.

Details:
The company and executive officers and directors have agreed with the underwriters, subject to certain exceptions, not to dispose of or hedge any shares of our common stock or securities convertible into or exchangeable for shares of our common stock during the period from the date of this prospectus continuing through the date 90 days (with respect to us) or 60 days (with respect to our executive officers and directors) after the date of this prospectus, except with the prior written consent of the representatives